Edgewise Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Edgewise Therapeutics generated cash of -$91,948,000, which is less than the previous year. Cash used in financing activities reached the amount of $53,166,000 last year. Net change in cash is therefore $64,104,000.
Cash Flow
| 2019 | -9.17M | -180K | 24.8M |
|---|---|---|---|
| 2020 | -14.63M | -24.38M | 120.27M |
| 2021 | -33.50M | -242.22M | 186.38M |
| 2022 | -52.63M | -70.57M | 129.63M |
| 2023 | -91.94M | 102.88M | 53.16M |
EWTX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 21.99M | 15.56M | 104.91M | 23.65M | 8.20M |
Operating activities | |||||
Net income | -100.16M | -67.64M | -42.81M | -17.12M | -9.70M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.73M | 538K | 272K | 185K | 123K |
Stock-based compensation expense | 17.56M | 10.92M | 4.40M | 354K | 77K |
| Deferred income tax benefit | 17.56M | 10.92M | 4.40M | 354K | 77K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -92K | 47K | 2.65M | 521K | 275K |
Cash generated by operating activities | -91.94M | -52.63M | -33.50M | -14.63M | -9.17M |
Investing activities | |||||
Purchases Of Investments | -255.86M | -292.38M | -288.20M | -24.17M | 0 |
Investments In Property Plant And Equipment | -5.74M | -5.54M | -668K | -203K | -180K |
Acquisitions Net | 0 | 65.03K | 241.55K | 0 | 0 |
Cash generated by investing activities | 102.88M | -70.57M | -242.22M | -24.38M | -180K |
Financing activities | |||||
Common Stock Issued | 52.61M | 129.16M | 186.14M | 120.27M | 24.8M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 53.16M | 129.63M | 186.38M | 120.27M | 24.8M |
Net Change In Cash | 64.10M | 6.42M | -89.35M | 81.26M | 15.44M |
Cash at end of period | 86.09M | 21.99M | 15.56M | 104.91M | 23.65M |
| Data source | Data source | Data source |